Literature DB >> 10170434

The transtheoretical model of health behavior change.

J O Prochaska1, W F Velicer.   

Abstract

The transtheoretical model posits that health behavior change involves progress through six stages of change: precontemplation, contemplation, preparation, action, maintenance, and termination. Ten processes of change have been identified for producing progress along with decisional balance, self-efficacy, and temptations. Basic research has generated a rule of thumb for at-risk populations: 40% in precontemplation, 40% in contemplation, and 20% in preparation. Across 12 health behaviors, consistent patterns have been found between the pros and cons of changing and the stages of change. Applied research has demonstrated dramatic improvements in recruitment, retention, and progress using stage-matched interventions and proactive recruitment procedures. The most promising outcomes to data have been found with computer-based individualized and interactive interventions. The most promising enhancement to the computer-based programs are personalized counselors. One of the most striking results to date for stage-matched programs is the similarity between participants reactively recruited who reached us for help and those proactively recruited who we reached out to help. If results with stage-matched interventions continue to be replicated, health promotion programs will be able to produce unprecedented impacts on entire at-risk populations.

Entities:  

Mesh:

Year:  1997        PMID: 10170434     DOI: 10.4278/0890-1171-12.1.38

Source DB:  PubMed          Journal:  Am J Health Promot        ISSN: 0890-1171


  1387 in total

1.  Community-level HIV intervention in 5 cities: final outcome data from the CDC AIDS Community Demonstration Projects.

Authors: 
Journal:  Am J Public Health       Date:  1999-03       Impact factor: 9.308

2.  Exploring information technology adoption by family physicians: survey instrument valuation.

Authors:  D R Dixon; M Stewart
Journal:  Proc AMIA Symp       Date:  2000

3.  Heterogeneity among smokers and non-smokers in attitudes and behaviour regarding smoking and smoking restrictions.

Authors:  B D Poland; J E Cohen; M J Ashley; E Adlaf; R Ferrence; L L Pederson; S B Bull; D Raphael
Journal:  Tob Control       Date:  2000-12       Impact factor: 7.552

Review 4.  Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library.

Authors:  T Lancaster; L Stead; C Silagy; A Sowden
Journal:  BMJ       Date:  2000-08-05

Review 5.  Factors affecting levels of physical activity in adults.

Authors:  Vern Seefeldt; Robert M Malina; Michael A Clark
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

6.  Using radon risk to motivate smoking reduction: evaluation of written materials and brief telephone counselling.

Authors:  E Lichtenstein; J A Andrews; M E Lee; R E Glasgow; S E Hampson
Journal:  Tob Control       Date:  2000-09       Impact factor: 7.552

7.  Psychometric assessment of Finnish versions of exercise-related measures of Transtheoretical Model constructs.

Authors:  Bradley J Cardinal; Kaisa J Tuominen; Pauli Rintala
Journal:  Int J Behav Med       Date:  2003

Review 8.  Health Behavior Theory to Enhance eHealth Intervention Research in HIV: Rationale and Review.

Authors:  Jane M Simoni; Keshet Ronen; Frances M Aunon
Journal:  Curr HIV/AIDS Rep       Date:  2018-12       Impact factor: 5.071

9.  Building an Evidence Base Using Qualitative Data for mHealth Development.

Authors:  Beth Bock; Rochelle Rosen; Herpreet Thind; Nancy Barnett; Kristen Walaska; Victoria Cobb
Journal:  Proc Annu Hawaii Int Conf Syst Sci       Date:  2014-01

10.  Patient-centered and efficacious advance care planning in cancer: Protocol and key design considerations for the PEACe-compare trial.

Authors:  Judith M Resick; Robert M Arnold; Rebecca L Sudore; David Farrell; Shane Belin; Andrew D Althouse; Betty Ferrell; Bernard J Hammes; Edward Chu; Douglas B White; Kimberly J Rak; Yael Schenker
Journal:  Contemp Clin Trials       Date:  2020-07-31       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.